Franjo Grotenhermen

Franjo Grotenhermen, born 1957, studied medicine, doctorate in Cologne. Clinical activity in internal medicine, surgery and naturopathy. Grotenhermen is head of the Centre for Cannabis Medicine in Steinheim (NRW), managing director of the Arbeitsgemeinschaft Cannabis als Medizin e.V. (ACM), managing director of the International Alliance for Cannabinoid Medicines (IACM) and Chief Medical Advisor of Telaleaf, a telemedicine company for therapy with cannabis-based medicines. He is co-owner of Endoxo, a company that distributes food and creams made from hemp, including CBD and CBG products. He is an employee of the Cologne-based nova Institute in the department of renewable resources and author of a large number of articles and books on the therapeutic potential of the hemp plant and cannabinoids, their pharmacology and toxicology.